Search

everythinglearnresearchcommunity

for

Search:↓

High levels of TNF-α may contribute to obesity and insulin resistance in PCOS, but not due to the C850T genetic variation.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Common Black hair care products may affect hormone levels and potentially impact health, especially in reproductive and metabolic areas.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

The study found that women with hyperandrogenic PCOS have higher levels of AKT1 and AKT2 proteins in their cells, which may lead to cell dysfunction.

A woman with cervical cancer had rare scalp metastasis causing a unique type of hair loss.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

These three weeds have important medicinal properties and need more research for potential pharmaceutical use.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

A woman had both Graham Little-Piccardi-Lassueur syndrome, causing hair loss, and complete androgen insensitivity syndrome, making her genetically male but physically female. This suggests androgens don't affect the hair loss condition.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Women with PCOS have more emotional and body image issues than healthy women.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Ashy dermatosis may be linked to atopy and thyroid disease and can be treated with topical steroids.

Newborn skin is uniquely prepared to adapt to new environments compared to adult skin.

Finasteride causes lasting fertility decrease in rats.

Sexual orientation does not affect the prevalence of PCOS or fertility rates in women undergoing artificial donor insemination.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Melatonin helped some Pomeranian dogs regrow hair, but it wasn't linked to estrogen receptors.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Melanoblasts migrate to the skin using various pathways, and understanding this process could help with skin disease research.